Yoshino Y - Search Results

1

BRCA1 transports the DNA damage signal for CDDP-induced centrosome amplification through the centrosomal Aurora A.

Qi H, Kikuchi M, Yoshino Y, Fang Z, Ohashi K, Gotoh T, Ideta R, Ui A, Endo S, Otsuka K, Shindo N, Gonda K, Ishioka C, Miki Y, Iwabuchi T, Chiba N. Qi H, et al. Among authors: yoshino y. Cancer Sci. 2022 Dec;113(12):4230-4243. doi: 10.1111/cas.15573. Epub 2022 Sep 21. Cancer Sci. 2022. PMID: 36082621 Free PMC article.

2

Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2.

Yoshino Y, Suzuki M, Takahashi H, Ishioka C. Yoshino Y, et al. Biochem Biophys Res Commun. 2015 Aug 14;464(1):275-80. doi: 10.1016/j.bbrc.2015.06.142. Epub 2015 Jun 24. Biochem Biophys Res Commun. 2015. PMID: 26116771

3

Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.

Yoshino Y, Ishioka C. Yoshino Y, et al. Sci Rep. 2015 Aug 21;5:13249. doi: 10.1038/srep13249. Sci Rep. 2015. PMID: 26292722 Free PMC article.

4

A Curcumin Analog, GO-Y078, Effectively Inhibits Angiogenesis through Actin Disorganization.

Sugiyama S, Yoshino Y, Kuriyama S, Inoue M, Komine K, Otsuka K, Kohyama A, Yamakoshi H, Ishioka C, Tanaka M, Iwabuchi Y, Shibata H. Sugiyama S, et al. Among authors: yoshino y. Anticancer Agents Med Chem. 2016;16(5):633-47. doi: 10.2174/1871520615666151013125559. Anticancer Agents Med Chem. 2016. PMID: 26459768

5

OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer.

Takahashi M, Chiba N, Shimodaira H, Yoshino Y, Mori T, Sumii M, Nomizu T, Ishioka C. Takahashi M, et al. Among authors: yoshino y. Breast Cancer. 2017 Mar;24(2):336-340. doi: 10.1007/s12282-016-0709-0. Epub 2016 Jun 6. Breast Cancer. 2017. PMID: 27271530

6

Regulation of the centrosome cycle.

Fujita H, Yoshino Y, Chiba N. Fujita H, et al. Among authors: yoshino y. Mol Cell Oncol. 2015 Jul 29;3(2):e1075643. doi: 10.1080/23723556.2015.1075643. eCollection 2016 Mar. Mol Cell Oncol. 2015. PMID: 27308597 Free PMC article. Review.

7

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.

Takahashi H, Takahashi M, Ohnuma S, Unno M, Yoshino Y, Ouchi K, Takahashi S, Yamada Y, Shimodaira H, Ishioka C. Takahashi H, et al. Among authors: yoshino y. BMC Cancer. 2017 Nov 7;17(1):723. doi: 10.1186/s12885-017-3739-x. BMC Cancer. 2017. PMID: 29115941 Free PMC article.

8

BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number.

Yoshino Y, Qi H, Fujita H, Shirota M, Abe S, Komiyama Y, Shindo K, Nakayama M, Matsuzawa A, Kobayashi A, Ogoh H, Watanabe T, Ishioka C, Chiba N. Yoshino Y, et al. Mol Cancer Res. 2018 Oct;16(10):1499-1511. doi: 10.1158/1541-7786.MCR-18-0269. Epub 2018 Jun 1. Mol Cancer Res. 2018. PMID: 29858377

9

RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells.

Yoshino Y, Qi H, Kanazawa R, Sugamata M, Suzuki K, Kobayashi A, Shindo K, Matsuzawa A, Shibata S, Endo S, Miyanishi Y, Shimaoka T, Ishioka C, Kanno SI, Yasui A, Chiba N. Yoshino Y, et al. Oncogene. 2019 Apr;38(16):3077-3092. doi: 10.1038/s41388-018-0647-8. Epub 2019 Jan 7. Oncogene. 2019. PMID: 30617304

10

Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency.

Yoshino Y, Endo S, Chen Z, Qi H, Watanabe G, Chiba N. Yoshino Y, et al. Sci Rep. 2019 Feb 7;9(1):1644. doi: 10.1038/s41598-018-38311-x. Sci Rep. 2019. PMID: 30733539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters